Research

Safety of adjuvanted pandemic influenza vaccines: background rate of narcolepsy in Europe


Reference:

Dieleman, J., Lecomte, C., Schuemie, M., van Rolleghem, A., Hviid, A., Svanstrom, H., Molgaard-Nielsen, D., Jokinen, J., Nohynek, H., Kilpi, T., Storsaeter, J., van der Maas, N., Heijbel, H., Arnheim-Dahlstrom, L., Sparen, P., Sammon, C., De Vries, C., Plazzi, G., Menna, A., Trotta, F., Santuccio, C., Johansen, K., Kramarz, P., Weibel, D., Bonhoeffer, J. and Sturkenboom, M., 2011. Safety of adjuvanted pandemic influenza vaccines: background rate of narcolepsy in Europe. Pharmacoepidemiology and Drug Safety, 20 (Supplement 1), S260.

Related documents:

This repository does not currently have the full-text of this item.
You may be able to access a copy if URLs are provided below. (Contact Author)

Official URL:

http://dx.doi.org/10.1002/pds.2206

Details

Item Type Articles
CreatorsDieleman, J., Lecomte, C., Schuemie, M., van Rolleghem, A., Hviid, A., Svanstrom, H., Molgaard-Nielsen, D., Jokinen, J., Nohynek, H., Kilpi, T., Storsaeter, J., van der Maas, N., Heijbel, H., Arnheim-Dahlstrom, L., Sparen, P., Sammon, C., De Vries, C., Plazzi, G., Menna, A., Trotta, F., Santuccio, C., Johansen, K., Kramarz, P., Weibel, D., Bonhoeffer, J. and Sturkenboom, M.
DOI10.1002/pds.2206
DepartmentsFaculty of Science > Pharmacy & Pharmacology
RefereedNo
StatusPublished
ID Code26288
Additional InformationMeeting abstract from the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk ManagementHyatt Regency Chicago, Chicago, Illinois, USA, August 14–17, 2011.

Export

Actions (login required)

View Item